AgingResearch.NewsJoin free

Cancer Prevention Pharmaceuticals

CompanyUnited StatesFounded 2008

RORWikidata

Cancer Prevention Pharmaceuticals develops one asset, in phase 3 (Eflornithine plus sulindac in colorectal neoplasm). Mostly small molecule; based in the United States, founded in 2008.

1
Asset
Furthest stage
Phase 3
Raised
$4.3M
3
Trials
0
Signals

Pipeline

1

  • Eflornithine plus sulindac

    Combines inhibition of polyamine synthesis and cyclooxygenases to prevent colorectal adenomas and second primary colorectal cancers.

    Phase 3, Small molecule, colorectal neoplasm

Full company profiles: pipeline, trials, funding and people.

See Pro

In the full profile

  • Trials6
  • Funding rounds and grants1
  • Similar companies6

Intelligence